M. Cantey Boyd
Board Member
Kiniksa Pharmaceuticals International, plc (KNSA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About M. Cantey Boyd
M. Cantey Boyd is recorded as Board Member at Kiniksa Pharmaceuticals International, plc (KNSA). Earlier roles on record: Board Member at Neurogene Inc. (NGNE) until December 18, 2023. Kiniksa Pharmaceuticals International, plc reported in an 8-K filed October 7, 2024 that M. Cantey Boyd was appointed member of the Class III directors, effective October 4, 2024. Neurogene Inc. reported in an 8-K filed December 19, 2023 that M. Cantey Boyd resigned as director, effective December 18, 2023.
“On October 4, 2024, the Board of Directors (the "Board") of Kiniksa Pharmaceuticals International, plc (the "Company") approved an increase in the number of directors constituting the Board from nine (9) to ten (10) directors and the appointment of M. Cantey Boyd, age 44, to the Board to fill the vacancy created thereby.”
“On the Separation Date, Martin Babler, M. Cantey Boyd, Erin Lavelle and Todd Simpson resigned from Neoleukin's board of directors and its committees on which they respectively served, which resignations were not the result of any disagreements with the Company relating to the Company's operations, policies or practices.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
-
2019-01-01–2023-12-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kiniksa Pharmaceuticals International, plc
Other people whose current roles at this company are on record from its filings.
- Sanj K. Patel CEO, Board Member
- Mark Ragosa CFO
- Ross Moat COO
- Michael Megna Chief Accounting Officer
- Barry D. Quart Board Member
- Felix J. Baker Board Member
- G. Bradley Cole Board Member
- Kimberly J. Popovits Board Member
- Richard S. Levy Board Member
- Stephen R. Biggar Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.